Bayesian Capital Management, LP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2016$6,000
-85.0%
16,200
-78.7%
0.00%
-89.5%
Q1 2016$40,000–76,100–0.04%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2016.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders